|
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
Recent news on
Ibandronate
Let's Make May the Month to Tame Osteoporosis Hype - May 23, 2007 Women's eNews,These include the bisphosphonates known as alendronate (brand name Fosamax), risedronate (Actonel) and ibandronate (Boniva); the hormone calcitonin
Osteoporosis Treatment -- Without Estrogen - May 13, 2007 Medical News Today (press release),Bisphosphonates available to treat osteoporosis include alendronate (Fosamax), ibandronate (Boniva) and risedronate (Actonel).
Once-yearly medication shown to significantly reduce bone ... - May 2, 2007 CNW Telbec (Communiqués de presse),Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal women. J Bone Miner Res 2004;19:1241-9.
Dr. Bill Elliott: Lifestyle changes can help prevent bone loss - May 21, 2007 Marin Independent-Journal,Bisphosphonate medications such as alendronate (Fosamax), risedronate (Actonel) and ibandronate (Boniva) are first-line treatment.
The Ultimate in Drug Adherence - May 16, 2007 HealthandAge.comRecently, a once-a-month tablet has become available - ibandronate, or Boniva®. Now we have the ultimate in aid to adherence - a once a year intravenous
Piribo: New Report on the Women's Health Pharmaceutical Market to 2011 - May 11, 2007 PR Web (press release),GSK's Boniva (ibandronate) indicated for the treatment of osteoporosis is forecast to accrue $1309m by the end of the forecast period in 2011.
Discover which Indications have the Greatest Potential to Provide ... - Apr 30, 2007 PharmaLive.com (press release),Of the newly launched products that are considered to be associated with strong potential success, GSK's Boniva (ibandronate) indicated for the treatment of
Focus on the Women's Health Market to 2011 - 26 Apr 2007 PharmaLive.com (press release),Of the newly launched products that are considered to be associated with strong potential success, GSK's Boniva (ibandronate) indicated for the treatment of
IV Ibandronate Injections Show Favourable Renal Tolerability in ... - Apr 16, 2007 DG NewsSEATTLE, WA -- April 16, 2007 -- The effect of IV ibandronate injections in postmenopausal women with normal renal function or mild to moderate renal
FDA approves new Actonel dose - Apr 19, 2007 News-Medical.net,With Actonel, patients can get their morning coffee up to 30 minutes sooner than with ibandronate 150 mg tablets, taken once monthly, which requires a wait
Skye formulation accepted for GSK drug - Apr 16, 2007 In-PharmaTechnologist.com,GSK highlights Requip as one of its 'rising stars' for 2007 sales (along with Avodart (Dutasteride) and Boniva/Bonviva (ibandronate)), though has cautioned
Bisphosphonate-associated necrosis of the jaws - Mar 28, 2007 Woman Dentist Journal,Commonly used oral bisphosphonates include tiludronate (Skelid), alendronate (Fosamax), risedronate (Actonel), etidronate (Didronel), and ibandronate
Vitamin D may prevent alcohol-related bone loss - Jan 30, 2007 Stuff.co.nz,New research conducted in rats now suggests that vitamin D or the anti-osteoporosis drug Boniva (ibandronate) can prevent alcohol-related bone loss caused
Update in Osteoporosis - 18 Jan 2007 Medscape (subscription)The newer nitrogen-containing bisphosphonates, including alendronate, risedronate, pamidronate, zoledronate, and now ibandronate, have increased the options
Vitamin D Or Boniva® (ibandronate) Reduces Bone Loss From Binge ... - Jan 1, 2007 Medical News Today (press release),Roche provided the ibandronate. For more information on Loyola University Health System, log onto http://www.loyolamedicine.org.
Vitamin D or Boniva® (ibandronate) Reduces Bone Loss from Binge ... - Dec 26, 2006 Newswise (press release)Roche provided the ibandronate. Loyola University Health System, a wholly owned subsidiary of Loyola University Chicago (LUC), includes the private teaching
Nancy Whelan: Osteoporosis medications can have side effects - Jan 5, 2007 Sebastian Sun (subscription),Bisphosphonate drugs (alendronate, ibandronate, risedronate, calcitonin, estrogens and raloxifene) work by affecting the bone remodeling cycle.
Alendronate Improves Screw Fixation in Osteoporotic Bone - Jan 2, 2007 Journal of Bone and Joint Surgery (subscription)In a murine study, the local delivery of ibandronate resulted in a substantial increase of 60% in the removal torque of stainless-steel screws two weeks
Oral Ibandronate Offers Palliative Befits to Patients Who Progress ... - Dec 19, 2006 DG NewsSAN ANTONIO, TX -- December 19, 2006 -- Second-line therapy with oral ibandronate can provide significant palliative benefits to patients with metastatic
Roche inks marketing pact with Elder - Dec 15, 2006 Business Standard,The Ibandronate tablet, priced above Rs 1 lakh in India, is one of the latest introductions by Roche in the bisphophonate segment.
Doctor: Osteoporosis should be a concern for women who smoke ... - Dec 7, 2006 49abcnews.com,Currently, bisphosphonates -- alendronate, ibandronate and risedronate -- calcitonin, estrogens, parathyroid hormone and raloxifene are approved by the US
Jawbone death risk small from medications - Dec 7, 2006 United Press International...take oral bisphosphonate drugs, a class of drugs that includes alendronate, or Fosamax; ibandronate, or Boniva; risedronate, or Actonel; and others.
Osteoporosis Meds And Jaw Pain: What's The Risk? - Dec 11, 2006 Medical News Today (press release),To treat osteoporosis, millions of Americans take oral bisphosphonate drugs, a class of drugs that includes alendronate (Fosamax), ibandronate (Boniva),
Phoenix II: JJ Yeley preview Nov 8, 2006 JJ Yeley, driver of the No. 18 Boniva (ibandronate sodium) Chevrolet for Joe Gibbs Racing, might have an idea of how Dorothy felt. ... -Motorsport.com,
What's going around Collier County Oct 25, 2006 The treatment for osteoporosis in men is the same as for women: alendronate, risendronate or ibandronate, along with calcium and vitamin D. If calcium intake ... -WBBH,
Cyclacel Pharmaceuticals Names John Womelsdorf, Ph.D., Vice ... Oct 24, 2006 ...and negotiating Roche's only global co-development/co-promotion agreement in a transaction with GlaxoSmithKline to commercialize ibandronate in osteoporosis. ... -PharmaLive.com (press release),
Women More Likely to Stay on Once-Monthly Ibandronate Versus Once ... Sep 18, 2006 18, 2006 -- According to six-month results of ongoing studies, women with postmenopausal osteoporosis taking once-monthly Boniva(R) (ibandronate sodium) were ... -DG News
Roche: Positive Study On Osteoporosis Drug Bonviva Sep 18, 2006 BASEL -(Dow Jones)- Swiss pharmaceutical company Roche Holding AG (RHHBY) Tuesday released a positive study on its osteoporosis drug ibandronate, or Bonviva. ... -Easy Bourse (Communiqués de presse)
Higher Persistency Rates Seen with FOSAMAX(R) Once Weekly ... Sep 19, 2006 ...rates were seen among osteoporosis patients taking FOSAMAX(R) Once Weekly (alendronate) therapies than were seen among patients taking ibandronate once monthly ... -Business Wire
Market Report -- In Play (MRK) Sep 19, 2006 ...rates were seen among osteoporosis patients taking Fosamax Once Weekly (alendronate) therapies than were seen among patients taking ibandronate once monthly or ... -MSN Money
Health — Pharmacy Q&A Sep 13, 2006 ...bisphosphonates. Others include Fosamax (alendronate), Boniva (ibandronate), Skelid (Tiludronate), and Didronel (etidronate). Aredia ... -The Stamford Times
Boniva advertising 'not misleading' says US judge Sep 8, 2006 Sanofi-Aventis and P&G's pharmaceuticals division had objected to DTC advertising for Boniva (ibandronate sodium), a bisphosphonate drug used to increase bone ... -Pharma Times (subscription)
Roche and GSK Win Key Ruling in US District Court on Boniva ... Sep 8, 2006 ...a move by their competitors to limit marketing activities in support of the once-monthly medicine for postmenopausal osteoporosis, Boniva® (ibandronate sodium ... -PharmaLive.com
Doctor: Osteoporosis should be a concern for women who smoke ... - Dec 7, 2006 49abcnews.com,Currently, bisphosphonates -- alendronate, ibandronate and risedronate -- calcitonin, estrogens, parathyroid hormone and raloxifene are approved by the US
Jawbone death risk small from medications - Dec 7, 2006 United Press International...take oral bisphosphonate drugs, a class of drugs that includes alendronate, or Fosamax; ibandronate, or Boniva; risedronate, or Actonel; and others.
Phoenix II: JJ Yeley race report - Nov 13, 2006 Motorsport.com,18 Boniva® (ibandronate sodium) Chevrolet for Joe Gibbs Racing, churned out another gritty performance, fighting back to finish 20th in front of his
Osteoporosis Meds And Jaw Pain: What's The Risk? - Dec 11, 2006 Medical News Today (press release),To treat osteoporosis, millions of Americans take oral bisphosphonate drugs, a class of drugs that includes alendronate (Fosamax), ibandronate (Boniva),
JJ Yeley Post-Race Notes: Checker Auto Parts 500 - Nov 13, 2006 WhoWon.com,After restarting 22nd on lap 230 , Yeley brought his Boniva® (ibandronate sodium) Chevrolet through the field and moved up to 18th by lap 271.
NASCAR: JOE GIBBS RACING race report - Phoenix - Nov 13, 2006 noticias.info (press release),18 Boniva® (ibandronate sodium) Chevrolet, finished 20th to secure his third straight top-20 finish. Hamlin continues to lead the trio of JGR drivers in the
COMBINING BISPHOSPHONATES WITH RALOXIFENE TO TREAT OSTEOPOROSIS: A ... Aug 21, 2006 A MEDLINE search (1966–February 2006) was conducted using the search terms osteoporosis, alendronate, risedronate, ibandronate, raloxifene, bisphosphonate ... -The Journal of Pharmacy Technology
Bonviva Effective as a Once-Monthly Oral Formulation for ... Jul 31, 2006 Ibandronate (ibandronic acid) once monthly (Bonviva 150mg) received a positive opinion on granting a marketing authorisation from the European Medicines ... -Business Portal 24
Prevention and Management of Bisphosphonate Toxicities Reviewed Aug 15, 2006 ...estimate that 2% of patients have serious complications after receiving intravenous Zometa® (zoledronic acid, Aredia® (pamidronate) or Boniva® (ibandronate ... -Cancer Consultants
Actress and Osteoporosis Advocate Sally Field Salutes Women's ... Aug 2, 2006 At that time, Field began an active osteoporosis management program and treats her condition with once-monthly Boniva(R) (ibandronate sodium), a prescription ... -PR Newswire
Monthly tablets help women persist longer with osteoporosis drugs 22 Jul 2006 ...a single 70mg dose of alendronate (marketed by Merck as Fosamax) once a week and the remainder received a single monthly 150mg dose of ibandronate (marketed as ... -Pharmaceutical Business Review
Self-tanning creams spark rashes, itching 16 May 2006 ...immediately. Your osteoporosis drug Actonel (risedronate) is in the same category as Fosamax (alendronate) and Boniva (ibandronate). ... - Charlotte Observer
Two-Year MOBILE Analysis of Ibandronate Validates Lumbar Spine and ... May 2, 2006 CHICAGO, IL -- May 2, 2006 -- A 2-year analysis of oral ibandronate for the treatment of postmenopausal osteoporosis shows that the treatment reduced markers ... - DG News
Intravenous Form and Labeling Approved for Ibandronate: Presented ... May 1, 2006 ...marrow density (BMD) as a proxy end-point for efficacy in reducing fractures among postmenopausal women, a study of intravenous (IV) ibandronate injections won ... - DG News
Intravenous Ibandronate May Be Associated With Higher Incidence of ... May 1, 2006 CHICAGO, IL -- May 1, 2006 -- While use of intravenous (IV) ibandronate may lead to a greater likelihood of developing an influenza-like illness, as well as ... - DG News
Rookie JJ Yeley to Drive Boniva Car on Mother's Day Weekend May 8, 2006 The sponsorship aims to help raise awareness about postmenopausal osteoporosis and once-monthly Boniva® (ibandronate sodium) tablets. ... - Auto Racing Daily
Sally Field's New Cause: Strong Bones May 10, 2006 Roche and GlaxosmithKline, makers of the drug Boniva (ibandronate sodium), are sponsoring Field's outreach and educational campaign. ... - Hartford Courant
Don't be dense -- osteoporosis can affect everyone -- even you May 3, 2006 Ibandronate (boniva) is the first monthly pill available to treat any chronic disease. It is also given every three months intravenously. ... - Petaluma Argus-Courier
Medical Files : Getting over the ‘hump’ Apr 28, 2006 Currently, bisphosphonates such as ibandronate (Bonviva), calcitonin, estrogens and parathyroid hormone are approved by the US Food and Drug Administration for ... - INQ7.net
Sally Field Brings Osteoporosis to Center Stage Apr 21, 2006 Bone Health" campaign. The two companies are the co-marketers of Boniva (ibandronate sodium), an osteoporosis medication. Through a ... - Forbes
Baby Boom Icon Sally Field Takes on New Leading Role As Women's ... Apr 20, 2006 Her doctor then recommended that she begin taking medicine, and he prescribed Boniva(R) (ibandronate sodium), a once-monthly tablet for postmenopausal ... - PharmaLive.com
Oral Ibandronate and IV May Be Equally Efficacious in Treating ... Mar 27, 2006 NICE, FRANCE -- March 27, 2006 -- Patients with metastatic bone disease due to breast cancer may respond equally well to oral ibandronate (Boniva) as they do ... - DG News
Roche Says EU Approves Bonviva (Ibandronate) as Quarterly ... Mar 31, 2006 Friday said they have received the European marketing authorization for the quarterly intravenous injection of the osteoporosis medication Bonviva (ibandronate ... - DG News
International Approvals: Lyrica and Bonviva Apr 3, 2006 ...a new indication for pregabalin, allowing its use in the treatment of generalized anxiety disorder, and an injectable formulation of ibandronate sodium for ... - Medscape (subscription)
Women With Osteoporosis Prefer One Tablet Per Month, Study Shows Mar 18, 2006 1. Hadji P, Benhamou CL, Devas V, Masanauskaite D, Barrett-Connor E. Women With Postmenopausal Osteoporosis Prefer Once-Monthly Oral Ibandronate to Weekly Oral ... - Medical News Today
New Bonviva Quarterly Injection Approved in Europe for ... Mar 31, 2006 DIVA compares the safety, efficacy and tolerability of the once-daily oral ibandronate 2.5mg regimen with two novel IV regimes: 2mg every two months and 3mg ... - PharmaLive.com
New Data Support Bondronat's Superior Renal Safety Profile Against ... Mar 24, 2006 Comparison of renal impairment in multiple myeloma patients treated with zoledronic acid or ibandronate: a retrospective review. ... - DG News
Roche says EU approves Bonviva as quarterly treatment Mar 31, 2006 Previous studies have shown that once-daily oral ibandronate reduced the risk of vertebral fracture in women with postmenopausal osteoporosis by 62% when taken ... - MarketWatch
Forecasts Tell Us That Bisphosphonates Will Remain the Mainstay of ... Mar 27, 2006 ...with 6.9% annual sales growth through our study period, driven by the emergence of two new agents: Roche/GlaxoSmithKline's ibandronate (Boniva/Bonviva) and ... - Genetic Engineering News
Innovative osteoporosis treatment, FOSAVANCE(TM), integrates two ... Mar 28, 2006 ...and second generation bisphosphonates and other commonly used anti-osteoporosis treatments through January 2005 (etidronate, ibandronate, miacalcin, pamidronate ... - Canada NewsWire
Lead May Be the Bullet Causing Osteoporosis in Senior Citizens Mar 27, 2006 The FDA has approved Boniva (ibandronate sodium) Injection as the first intravenous medication for the treatment of postmenopausal osteoporosis, Roche and ... - SeniorJournal.com
New Study Shows Women With Osteoporosis Preferred Once-Monthly ... Mar 17, 2006 ...two-thirds (70%) of women with postmenopausal osteoporosis, who expressed a preference, preferred once-monthly dosing with Boniva(R) (ibandronate sodium) over ... - DG News
Double boost for Bonviva in osteoporosis Mar 20, 2006 Roche and GSK will see BALTO II results as a plus for Bonviva (ibandronate) - currently the only once-monthly oral treatment for osteoporosis - especially as ... - Pharma Times (subscription)
Bisphosphonate Safety Evaluation Shows General Safety: Presented ... Feb 21, 2006 VIENNA, AUSTRIA -- February 21, 2006 -- While oral ibandronate (Bondronat(R)) provides decreased incidence of skeletal-related effects, rapid and sustained ... - DG News
Older Men Surviving Heart Attack at Higher Risk of Osteoporosis Feb 21, 2006 The FDA has approved Boniva (ibandronate sodium) Injection as the first intravenous medication for the treatment of postmenopausal osteoporosis. Read more... ... - SeniorJournal.com,
Scots get new drug to fight against bone disease Feb 13, 2006 Bonviva, also known as ibandronate, was approved for post-menopausal women with osteoporosis for use across the NHS by the Scottish Medicines Consortium. ... - Scotsman,
Scottish Medicines Consortium Approves Bonviva® - Scottish Women ... Feb 14, 2006 Several thousand women across Scotland will now have access to a new drug called Bonviva® (ibandronic acid also known as ibandronate), following its approval ... - Medical News Today,
FDA Approves First IV Treatment for Postmenopausal Osteoporosis ... Jan 9, 2006 NUTLEY, NJ, and RESEARCH TRIANGLE PARK, NC -- January 9, 2006 -- The US Food and Drug Administration (FDA) has approved Boniva(R) (ibandronate sodium) Injection ... - DG News
European positive opinion for first quarterly IV injection for Jan 27, 2006 DIVA compares the safety, efficacy and tolerability of the approved once-daily oral ibandronate 2.5mg regimen with two novel IV regimes: 2mg every two months ... - WebWire
FDA approves first quarterly IV injection for postmenopausal ... Jan 9, 2006 Gorana Dasic, the US Ibandronate Medical Director at GSK said: "Boniva Injection is the first IV bisphosphonate to be approved for osteoporosis treatment ... - Biotech Intelligence
It is Predicted in the Next Ten Years the Demand for Drugs to ... Feb 3, 2006 ...with 6.9% annual sales growth through our study period, driven by the emergence of two new agents: Roche/GlaxoSmithKline's ibandronate (Boniva/Bonviva) and ... - International News Service
Boniva for injection cleared in USA Jan 9, 2006 Boniva for injection (ibandronate sodium), developed by GlaxoSmithKline and Roche, is aimed at people who find it hard to adhere to treatment with the current ... - Pharma Times (subscription)
Osteoporosis Information Now Online at NIHSeniorHealth Jan 27, 2006 The FDA has approved Boniva (ibandronate sodium) Injection as the first intravenous medication for the treatment of postmenopausal osteoporosis, Roche and ... - SeniorJournal.com
FDA Approves First IV Treatment for Postmenopausal Osteoporosis ... Jan 6, 2006 6 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved Boniva(R) (ibandronate sodium) Injection, the first intravenous (IV) medication for ... - PR Newswire
Companies say FDA approves IV version of postmenopausal ... Jan 9, 2006 Boniva Injection, formally known as ibandronate sodium, becomes the first intravenous drug for the treatment of postmenopausal osteoporosis, Roche and ... - Redlands Daily Facts
Business Briefing Jan 7, 2006 Boniva Injection, formally known as ibandronate sodium, becomes the first intravenous drug for the treatment of postmenopausal osteoporosis, Roche and ... - The Ledger
This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional
|